Company Data

Delcath Systems Inc.

Ticker
DCTH
Current Price
$14.88 -4.25%
Market Cap
$475.8M
Price Target
Refer to Report
Volume
240.3K
52wk Range
$3.7 - $16.97
Advanced Market Data

Overview

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm’s product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy